Influence of epidermal growth factor and gastrin on the cell proliferation of human meningiomas versus astrocytic tumors maintained as ex vivo tissue cultures

Neuropeptides

Volumn 31, Issue 3, 1997, Pages 217-225

  Camby, I ^a   Nagy, N ^b   Rombaut, K ^b   Gras, T ^a   Duponchelle, C ^b   Pasteels, J L ^a   Brotchi, J ^b   Kiss, R ^a,c   Salmon, I ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOSIS; AUTORADIOGRAPHY; BRAIN TUMOR; CELL GROWTH; CELL PROLIFERATION; HORMONAL REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MENINGIOMA; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE CULTURE; TUMOR GROWTH;

EID: 0030833867     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90051-2     Document Type: Article

References (47)

1. Kleihues P, Burger PC, Scheithauer BW. Histological typing of the tumours of the central nervous system. 2nd edn. World Health Organization. Springer-Verlag, 1992.
2. Loeffler JS, Shrieve DC, Coleman CN. Chemoradiation and adjuvant chemotherapy for glioblastoma: Why does so much therapy yield so little improvement in survival. Int J Radiat Oncol Biol Phys 1995; 33: 531-533.
3. Mulshine JL, Shuke N, Daghighian F et al. The correct dose: pharmacologically guided end point for anti-growth factor therapy. Cancer Res 1992; 52: 2743s-2746s.
4. Grunberg SM. Role of antiprogestational therapy for meningiomas. Human Reproduction 1994; 9 Suppl 1: 202-207
5. Cushing HW. Intracranial tumours: notes on a series of two thousand verified cases with surgical mortality percentages pertaining thereto. Anonymous Baltimore: Charles C Thomas, 1932.
6. Blankenstein MA, Koehorst SGA, Van der Kallen CJH et al. Oestrogen receptor independent expression of progestin receptors in human meningioma - A review. J Steroid Biochem Mol Biol 1995; 53: 361-365.
7. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 1993; 33: 212-218.
8. Olson JJ. Laboratory evidence for the hormonal dependency of meningiomas. Hum Reprod 1994; 9 suppl 1: 195-201.
9. Carroll RS, Zhang J, Dashner K, Black PM. Progesterone and glucocorticoid receptor activation in meningiomas. Neurosurgery 1995; 37: 92-97
10. Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM. Androgen receptor expression in meningiomas. J Neurosurg 1995; 82: 453-460.
11. Jay J, MacLaughlin DT, Riley KR, Martuza RL. Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 1985; 62: 757-762.
12. Adams EF, Schrell UM, Fahlbusch R, Thierauf P. Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 1990; 73: 750-755.
13. Weisman AS, Villemure JG, Kelly PA. Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 1986; 46: 2545-2550.
14. Courrière P, Tremoulet M, Eche N, Armand JP. Hormonal steroid receptors in intracranial tumors and their relevance in hormone therapy. Eur J Cancer [A] 1985; 21: 711-714.
15. Rao BR, Roelvink CA, Slotman BJ. Role of steroid hormones in gliomas. In: Glioma, Principles and Practice in Neuro-oncology. Karim ABMF, Laws ER, eds. Berlin: Springer-Verlag, 1991: 165.
16. Langeveld CH, van Waas MP, Stoof JC et al. Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. J Cell Sci 1992; 31: 524-531.
17. Carroll RS, Zhang JP, Dashner K, Sar M, Black PM. Steroid hormone receptors in astrocytic neoplasms. Neurosurgery 1995; 37: 496-503.
18. Camby I, Salmon I, Danguy A et al. Influence of gastrin on human astrocytic tumor cell proliferation. J Natl Cancer Inst 1996; 88: 594-600.
19. Camby I, Salmon I, Rorive S et al. Characterization of the influence of anti-hormone and/or growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines. J Neurooncol 1994; 20: 67-80.
20. Camby I, Salmon I, Bourdel E et al. Neurotensin-mediated effects on astrocytic tumor cell proliferation. Neuropeptides 1996; 30: 133-139.
21. Takahashi JA, Mori H, Fukumoto M et al. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. PNAS 1990; 87: 5710-5714.
22. Nishikawa R, Ji X-D, Harmon RC et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. PNAS 1994; 91: 7727-7731.
23. Sang UH, Espiritu OD, Kelley PY, Klauber MR, Hatton JD. The role of the epidermal growth factor receptor in human gliomas: I. The control of cell growth. J Neurosurg 1995; 82: 841-846.
24. Von Deimling A, Louis DN, Wiestler OD. Molecular pathways in the formation of gliomas. Glia 1995; 15: 328-338.
25. Merchant JL, Shiotani A, Mortensen ER, Shumaker DK, Abraczinskas DR. Epidermal growth factor stimulation of the human gastrin promoter requires Sp1. J Biol Chem 1995; 270: 6314-6319.
26. Darro F, Camby I, Kruczynski A, Pasteels J, Martinez J, Kiss R. Characterization of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol and anti-luteinizing hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract. Gut 1995; 36: 220-230.
27. Al-Mefty O, ed. Meningiomas. New York: Raven Press, 1991.
28. Remmelink M, Salmon I, Goldschmidt D et al. Quantitative measurements of desmin and vimentin immunostains and cell density in leiomyomas and leiomyosarcomas. Anal Cell Pathol 1996; 12: 25-44.
29. Mauro A, Di Sapio A, Mocellini C, Schiffer D. Control of meningioma cell growth by platelet-derived growth factor (PDGF). J Neurol Sci 1995; 131: 135-143.
30. Dorward NL, Hawkins RA, Whittle IR. Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma. Br J Neurosurg 1993; 7: 197-199.
31. Figarella-Branger D, Vagner-Capodano AM, Bouillot P et al. Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: Correlations with clinicopathological features and cytogenetic analysis. Neuropathol Appl Neurobiol 1994; 20: 439-447.
32. Hermanson M, Funa K, Hartman M et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992; 52: 3213-3219.
33. Rehfeld JF, Van Solinge WW. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994; 63: 295-347.
34. 2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res 1992; 52: 6031-6035.
35. Seva C, Dickinson, CJ, Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994; 265: 410-412.
36. Hokfelt T, Cortes R, Schalling M et al. Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues. Neuropeptides 1991; 19: 31-43.
37. Vanderhaeghen JJ, Lotstra F, De Mey J, Gilles C. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. PNAS 1980; 77: 1190-1194.
38. Rehfeld JF. Progastrin and its products in the cerebellum. Neuropeptides 1991; 20: 239-245.
39. Rehfeld JF, Kruse-Larsen C. Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity. Brain Res 1978; 155: 19-26.
40. Mailleux P, Vanderhaeghen JJ. Cholecystokinin receptors of A type in the human dorsal medulla oblongata and meningiomas, and of B type in small cell lung carcinomas. Neurosci Lett 1990; 117: 243-247.
41. Bold RJ, Alpard S, Ishizuka J, Townsend CM, Thompson JC. Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase. A isoform content. Regulatory Peptides 1994; 53: 61-70.
42. Chicoine MR, Madsen CL, Silbergeld DL. Modification of human glioma locomotion in vitro by cytokines EGF, bFGF, PDGFbb, NGF, and TNFa. Neurosurgery 1995; 36: 1165-1171.
43. Torp SH, Helseth E, Dalen A, Unsgaard G. Expression of epidermal growth factor receptor in human meningiomas and meningial tissue. APMIS 1992; 100: 797-802.
44. Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J Neurol 1995; 242: 683-688.
45. Koper JW, Lamberts WJ. Meningiomas, epidermal growth factor and progesterone. Hum Reprod 1994; 9 Supp 1: 190-194.
46. Kiss R, de Launoit Y, Danguy A, Paridaens RJ, Pasteels J. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Cancer Res 1989; 49: 2945-2951.
47. Kiss R, Salmon I, Pauwels O et al. In vitro influence of gastrin, estradiol and gonadotrophin releasing hormone on HCT-15 and LoVo human colorectal neoplastic cell proliferation. Eur J Cancer 1991; 27: 1268-1274.